These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16205560)

  • 1. Primary intravitreal triamcinolone acetonide for diabetic massive macular hard exudates.
    Khairallah M; Zeghidi H; Ladjimi A; Yahia SB; Attia S; Zaouali S; Messaoud R
    Retina; 2005; 25(7):835-9. PubMed ID: 16205560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.
    Avci R; Kaderli B
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):28-35. PubMed ID: 16034605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Er H; Yilmaz H
    Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal triamcinolone acetonide for diabetic macular edema.
    Chieh JJ; Roth DB; Liu M; Belmont J; Nelson M; Regillo C; Martidis A
    Retina; 2005; 25(7):828-34. PubMed ID: 16205559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone injection for chronic diffuse diabetic macular oedema.
    Avci R; Kaderli B; Akalp FD
    Clin Exp Ophthalmol; 2006; 34(1):27-32. PubMed ID: 16451255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone for refractory diabetic macular edema.
    Martidis A; Duker JS; Greenberg PB; Rogers AH; Puliafito CA; Reichel E; Baumal C
    Ophthalmology; 2002 May; 109(5):920-7. PubMed ID: 11986098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
    Ozdemir H; Karacorlu M; Karacorlu SA
    Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series.
    Bakri SJ; Beer PM
    Can J Ophthalmol; 2004 Dec; 39(7):755-60. PubMed ID: 15696765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.
    Ciardella AP; Klancnik J; Schiff W; Barile G; Langton K; Chang S
    Br J Ophthalmol; 2004 Sep; 88(9):1131-6. PubMed ID: 15317702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series.
    Nicolò M; Nasciuti F; Lai S; Ghiglione D; Borgia L; Calabria G
    Eur J Ophthalmol; 2006; 16(1):129-33. PubMed ID: 16496256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema.
    Ozkiris A; Evereklioglu C; Erkiliç K; Tamçelik N; Mirza E
    Eur J Ophthalmol; 2004; 14(6):543-9. PubMed ID: 15638105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
    Sutter FK; Simpson JM; Gillies MC
    Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
    Jonas JB; Kreissig I; Söfker A; Degenring RF
    Arch Ophthalmol; 2003 Jan; 121(1):57-61. PubMed ID: 12523885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
    Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
    Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide.
    Jonas JB; Harder B; Kamppeter BA
    Am J Ophthalmol; 2004 Dec; 138(6):970-7. PubMed ID: 15629288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of reduction of plaque-like hard exudates in diabetic macular edema after intravitreal triamcinolone injection.
    Cekiç O; Bardak Y; Tiğ US; Yildizoğlu U; Bardak H
    Int Ophthalmol; 2008 Apr; 28(2):95-9. PubMed ID: 17634861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.